A Randomized Trial of a Skin Sealant to Reduce the Risk of Incision Contamination in Cardiac Surgery
Carregando...
Citações na Scopus
30
Tipo de produção
article
Data de publicação
2011
Editora
ELSEVIER SCIENCE INC
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
ECKARDSTEIN, Abelardo Silva von
LIM, Chong H.
DOHMEN, Pascal M.
COOPER, William A.
OSLUND, Susan G.
KELLEY, E. Lynne
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
ANNALS OF THORACIC SURGERY, v.92, n.2, p.632-637, 2011
Resumo
Background. Immobilizing skin microbes is a rational approach to reducing contamination of surgical sites by endogenous microorganisms. Methods. This randomized, controlled, parallel-group, multicenter, open-label clinical trial (ClinicalTrials.gov NCT00467857) enrolled 300 adults scheduled for elective coronary artery bypass graft surgery. Patients received iodine-based skin preparations followed by a cyanoacrylate-based skin sealant or skin preparations alone. Microbiological samples collected from sternal and graft incision sites immediately before any skin preparation, at the wound border after skin incision, and at the incision after fascial closure were evaluated quantitatively. Results. In evaluable patients, mean microbial counts in collected samples increased at the sternal site after fascial closure compared with after skin incision by 0.37 log(10) colony-forming units (CFU)/mL in the skin sealant group (n = 120) and by 0.57 log10 CFU/mL in the control group (n = 132) (p = 0.047, Wilcoxon rank sum test). At the graft site, mean microbial counts increased by 0.09 (n = 119) and 0.27 (n = 127) log(10) CFU/mL, respectively (p = 0.037). There was a 35.3% relative risk reduction in surgical site infection (SSI) occurring in the skin sealant group (9 of 146 patients, 6.2%) versus the control group (14 of 147 patients, 9.5%). In obese patients (body mass index [BMI] > 30.0 to <= 37.0 kg/m(2)), the relative risk reduction for SSI associated with skin sealant was 83.3%. Conclusions. Pretreatment with skin sealant protects against contamination of the surgical incision by migration of skin microbes. Further data are needed to confirm the impact of this technology on SSI rates in clinical practice. (Ann Thorac Surg 2011;92:632-7) (C) 2011 by The Society of Thoracic Surgeons ADULT CARDIAC
Palavras-chave
Referências
- Haas JP, 2005, HEART LUNG, V34, P108, DOI 10.1016/j.hrtlug.2004.02.004
- Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X
- Tunney MM, 1999, J CLIN MICROBIOL, V37, P3281
- de Lissovoy G, 2009, AM J INFECT CONTROL, V37, P387, DOI 10.1016/j.ajic.2008.12.010
- Fowler VG, 2005, CIRCULATION, V112, pI358, DOI 10.1161/CIRCULATIONAHA.104.525790
- Graf K, 2010, EUR J CARDIO-THORAC, V37, P893, DOI 10.1016/j.ejcts.2009.10.005
- Ridderstolpe L, 2001, EUR J CARDIO-THORAC, V20, P1168, DOI 10.1016/S1010-7940(01)00991-5
- Bowler PG, 2001, CLIN MICROBIOL REV, V14, P244, DOI 10.1128/CMR.14.2.244-269.2001
- Saltzman MD, 2009, J BONE JOINT SURG AM, V91A, P1949, DOI 10.2106/JBJS.H.00768
- Kuhme T, 2007, APMIS, V115, P1001, DOI 10.1111/j.1600-0463.2007.00832.x
- Dohmen PM, 2009, J HOSP INFECT, V72, P119, DOI 10.1016/j.jhin.2009.02.005
- Chow S. C., 2003, SAMPLE SIZE CALCULAT
- Snedecor G. W., 1973, STAT METHODS
- Towfigh S, 2008, ARCH SURG-CHICAGO, V143, P885, DOI 10.1001/archsurg.143.9.885